- Papers in database
- 19
- Primary author
- 6 papers
- Years active
- 2009 – 2021
- Health outcomes studied
- 13
Health Outcomes Studied
- Improved Gut Microbiota Composition
- Increased Bifidobacteria Count
- Increased Bifidobacteria Levels
- Increased Fecal Bifidobacteria Levels
- Increased Fecal Immunoglobulin A Levels
- Increased Presence of Bifidobacterium lactis
- Increased Probiotic B. lactis Levels
- Reduced Body Mass Index
- Reduced Diarrhea Rate
- Reduced Faecal pH
- Reduced Fecal Microbiota Diversity
- Reduced Stool Volume
- Reduced Vomiting Frequency
Papers (19)
- 2021Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial10.1136/bmjdrc-2020-001523
- 2019Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.10.1097/INF.0000000000002355
- 2019Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.10.1016/j.cmi.2018.08.017
- 2019Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update10.3390/nu11112762
- 2018Primary authorLactobacillus rhamnosus GG in the Primary Prevention of Eczema in Children: A Systematic Review and Meta-Analysis10.3390/nu10091319
- 2018Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis10.1542/peds.2017-1811
- 2017Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial10.1136/bmjopen-2016-013928
- 2016Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial10.1097/INF.0000000000000948
- 2016Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446.10.1111/1462-2920.13144
- 2014The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence10.1007/s00431-014-2328-0
- 2014Primary authorMeta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.10.3920/BM2013.0056
- 2013Primary authorGrowth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials10.1186/1471-2431-13-185
- 2013Primary authorMeta‐analysis shows limited evidence for using Lactobacillus acidophilus LB to treat acute gastroenteritis in children10.1111/apa.12487
- 2013Primary authorLactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.10.1016/j.jpeds.2012.08.004
- 2012Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial.10.1016/j.jpeds.2011.12.049
- 2011Fermented Milk Containing Bifidobacterium lactis DN-173 010 in Childhood Constipation: A Randomized, Double-Blind, Controlled Trial10.1542/peds.2010-2590
- 2010Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial.10.1016/j.clnu.2009.09.008
- 2010Primary authorEffect of Bifidobacterium animalis subsp lactis Supplementation in Preterm Infants: A Systematic Review of Randomized Controlled Trials10.1097/MPG.0b013e3181dc0d93
- 2009Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Controlled Pilot Trial10.1159/000151300